Targeting Type 1 Diabetes

Madison Carter is a fearless investigative reporter. She takes no day for granted because she lives with type 1 diabetes (T1D). Dr. Doug Melton is a world-renowned stem cell researcher and distinguished fellow at Vertex – and his now grown children, Sam and Emma, live with T1D. Along with scientists like Dr. Felicia Pagliuca, who leads Vertex’s research into T1D, he’s been on a quest to help Madison, Sam, Emma, and others like them by investigating the disease at a cellular level. 

Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. 

Featured guests:

Madison Carter is an investigative journalist with 11Alive News, an NBC affiliate in Atlanta, GA. She's living with type 1 diabetes. 

Aaron Kowalski is the President and CEO of Breakthrough T1D.

Felicia Pagliuca leads research in cell and genetic therapies at Vertex Pharmaceuticals.

Doug Melton leads investigations into treatments for type 1 diabetes at Vertex Pharmaceuticals. He is renowned for his stem cell research at Harvard University. Read more about Vertex's approach to targeting type 1 diabetes.

Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.